Chunjing Wu

1.3k total citations
38 papers, 1.0k citations indexed

About

Chunjing Wu is a scholar working on Molecular Biology, Biotechnology and Cancer Research. According to data from OpenAlex, Chunjing Wu has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Biotechnology and 10 papers in Cancer Research. Recurrent topics in Chunjing Wu's work include Cancer Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Virus-based gene therapy research (7 papers). Chunjing Wu is often cited by papers focused on Cancer Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Virus-based gene therapy research (7 papers). Chunjing Wu collaborates with scholars based in United States, Taiwan and Netherlands. Chunjing Wu's co-authors include Niramol Savaraj, Medhi Wangpaichitr, Lynn G. Feun, Min You, Théodore J. Lampidis, Macus Tien Kuo, George Theodoropoulos, Yingying Li, M. Tien Kuo and Dao M. Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Chunjing Wu

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunjing Wu United States 19 540 315 278 178 150 38 1.0k
Yuji Yaginuma Japan 19 646 1.2× 424 1.3× 208 0.7× 60 0.3× 164 1.1× 51 1.2k
Russell Ericksen United States 14 523 1.0× 305 1.0× 271 1.0× 42 0.2× 144 1.0× 22 1.0k
Subbulakshmi Virudachalam United States 18 705 1.3× 381 1.2× 274 1.0× 146 0.8× 98 0.7× 21 1.2k
Alessio Giubellino United States 21 605 1.1× 329 1.0× 308 1.1× 26 0.1× 128 0.9× 77 1.3k
Fatih Ceteci Germany 14 923 1.7× 413 1.3× 503 1.8× 65 0.4× 151 1.0× 17 1.4k
Mustafa Vali United States 15 470 0.9× 181 0.6× 355 1.3× 70 0.4× 41 0.3× 17 884
Hsu-Ping Kuo United States 12 892 1.7× 274 0.9× 187 0.7× 50 0.3× 167 1.1× 12 1.1k
Aki Pui‐Wah Tse Hong Kong 14 764 1.4× 358 1.1× 600 2.2× 35 0.2× 386 2.6× 17 1.4k
Pin Yi China 11 797 1.5× 258 0.8× 606 2.2× 40 0.2× 290 1.9× 14 1.3k
Alisha M. Mendonsa United States 7 478 0.9× 268 0.9× 227 0.8× 27 0.2× 99 0.7× 8 865

Countries citing papers authored by Chunjing Wu

Since Specialization
Citations

This map shows the geographic impact of Chunjing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunjing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunjing Wu more than expected).

Fields of papers citing papers by Chunjing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunjing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunjing Wu. The network helps show where Chunjing Wu may publish in the future.

Co-authorship network of co-authors of Chunjing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunjing Wu. A scholar is included among the top collaborators of Chunjing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunjing Wu. Chunjing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagarajan, M. K., et al.. (2025). Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy. Journal of Personalized Medicine. 15(2). 50–50. 5 indexed citations
2.
Knott, Eric P., Emily Kim, Yujie Wang, et al.. (2024). Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy. Cells. 13(13). 1120–1120. 3 indexed citations
3.
Wu, Chunjing, S. Spector, George Theodoropoulos, et al.. (2023). Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer. SHILAP Revista de lepidopterología. 11(1). 7–7. 30 indexed citations
4.
Theodoropoulos, George, Chunjing Wu, Wei Sha, et al.. (2019). Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer. Molecular Cancer Research. 18(1). 105–117. 41 indexed citations
5.
Feun, Lynn G., Yingying Li, Chunjing Wu, et al.. (2019). Plasma biomarkers to predict pembrolizumab response in HCC patients.. Journal of Clinical Oncology. 37(15_suppl). e14043–e14043. 1 indexed citations
6.
Wangpaichitr, Medhi, et al.. (2019). Abstract 4361: Kynurenine - Aryl hydrocarbon receptor axis: A crucial modulator of immunometabolism in cisplatin resistant lung cancer. Cancer Research. 79(13_Supplement). 4361–4361. 1 indexed citations
7.
Zhu, Xiaoqing, Jiali Yang, Yanfeng Gao, et al.. (2017). The dual effects of a novel peptibody on angiogenesis inhibition and M2 macrophage polarization on sarcoma. Cancer Letters. 416. 1–10. 22 indexed citations
8.
Wu, Chunjing, Medhi Wangpaichitr, Panida Navasumrit, et al.. (2017). The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma. International Journal of Molecular Sciences. 18(6). 1175–1175. 27 indexed citations
9.
Savaraj, Niramol, Chunjing Wu, Yingying Li, et al.. (2015). Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget. 6(8). 6295–6309. 32 indexed citations
10.
Wangpaichitr, Medhi, Chunjing Wu, Gregory E. Bigford, et al.. (2014). Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma.. PubMed. 34(12). 6991–9. 13 indexed citations
11.
Wangpaichitr, Medhi, Elizabeth J. Sullivan, George Theodoropoulos, et al.. (2012). The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells. Molecular Cancer Therapeutics. 11(3). 604–615. 67 indexed citations
12.
You, Min, Niramol Savaraj, Macus Tien Kuo, et al.. (2012). TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Molecular and Cellular Biochemistry. 374(1-2). 181–190. 54 indexed citations
13.
You, Min, Niramol Savaraj, Medhi Wangpaichitr, et al.. (2010). The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines. Biochemical and Biophysical Research Communications. 394(3). 760–766. 25 indexed citations
14.
Wangpaichitr, Medhi, Chunjing Wu, Min You, et al.. (2008). Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. European Journal of Pharmacology. 591(1-3). 124–127. 59 indexed citations
15.
Savaraj, Niramol, Chunjing Wu, Min You, et al.. (2007). The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations
16.
Savaraj, Niramol, Chunjing Wu, Min You, et al.. (2007). The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.. PubMed. 2. 119–28. 27 indexed citations
17.
Wu, Chunjing, et al.. (2005). Overcoming cisplatin resistance by mTOR inhibitor in lung cancer. Molecular Cancer. 4(1). 25–25. 104 indexed citations
18.
Savaraj, Niramol, Chunjing Wu, Howard J. Landy, et al.. (2005). Procollagen Alpha 1 Type I: A Potential Aide in Histopathological Grading of Glioma. Cancer Investigation. 23(7). 577–581. 8 indexed citations
19.
Feun, Lynn G., et al.. (2004). G-quartet oligonucleotides: A new class of Stat3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Cancer Research. 64. 1054–1054. 13 indexed citations
20.
Savaraj, Niramol, Chunjing Wu, Medhi Wangpaichitr, et al.. (2003). Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: Collateral sensitivity to azidothymidine. International Journal of Oncology. 23(1). 173–9. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuji Yaginuma Breakdown of academic impact, for papers by Russell Ericksen Breakdown of academic impact, for papers by Subbulakshmi Virudachalam Breakdown of academic impact, for papers by Alessio Giubellino Breakdown of academic impact, for papers by Fatih Ceteci Breakdown of academic impact, for papers by Mustafa Vali Breakdown of academic impact, for papers by Hsu-Ping Kuo Breakdown of academic impact, for papers by Aki Pui‐Wah Tse Breakdown of academic impact, for papers by Pin Yi Breakdown of academic impact, for papers by Alisha M. Mendonsa
Rankless by CCL
2026